Zacks Investment Research on MSN
Can Alnylam's drug pipeline fuel its long-term revenue growth?
Alnylam Pharmaceuticals ALNY currently markets four approved drugs — Onpattro, Givlaari, Oxlumo and Amvuttra — that together ...
Futures are trading higher as we get ready to start the first full week of trading for the third quarter, as traders and ...
Once held back by centuries of colonial rule and decades of violent conflict, Dublin transformed into one of Europe's ...
Discover 5 top Big Pharma stocks amid rising cancer, type 2 diabetes and IMIDs—dividend yields, earnings beats and why they ...
Four stocks on the S&P 500 pay out dividends of more than 6% -- not including a couple that are real estate investment trusts ...
Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to buy, according to hedge funds. On June 24, the US Food and Drug ...
Zoetis has seen its valuation compress dramatically, now trading at just 12x trailing earnings after a 52% 12-month share ...
Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine ...
Knoa Pharma's new CEO, Michael Goettler, will lead a company that was created through Purdue Pharma's bankruptcy process.
Congressional letters sent to the CEOs of Eli Lilly, Pfizer, Merck, BMS and AbbVie this week voicing concerns about the pharmas’ clinical trials in China highlight an ongoing discrepancy in how ...
Nicola met dozens of other women with the same rare tumours and one thing in common - they all took the Depo Provera jab over ...
The U.S. House Select Committee on China has opened investigations into five pharmaceutical companies regarding their clinical trials in China, questioning whether the drugmakers may have aided the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results